HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philippe Beauchemin Selected Research

Therapeutics

2/2016MS arising during Tocilizumab therapy for rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philippe Beauchemin Research Topics

Disease

1Primary Myelofibrosis (Myelosclerosis)
06/2022
1Autoimmune Diseases (Autoimmune Disease)
06/2022
1Vasculitis (Vasculitides)
06/2022
1Guillain-Barre Syndrome
06/2022
1Relapsing-Remitting Multiple Sclerosis
06/2022
1Brain Diseases (Brain Disorder)
01/2022
1COVID-19
01/2022
1Infections
01/2022
1Multiple Sclerosis
12/2016
1Neuromyelitis Optica (Devic's Disease)
12/2016
1Rheumatoid Arthritis
02/2016

Drug/Important Bio-Agent (IBA)

2tocilizumab (atlizumab)FDA Link
12/2016 - 02/2016
1Alemtuzumab (Campath)FDA Link
06/2022
1VaccinesIBA
01/2022
1COVID-19 VaccinesIBA
01/2022

Therapy/Procedure

1Therapeutics
02/2016